Top Markets
Coin of the day
BioHarvest Sciences Inc. Common Stock BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

BHST
Rang in Aktien #27032
BioHarvest Sciences Inc. functions as a biotechnology firm with operations... BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Aktienkurs
$2.06
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$35.61M
Veränderung (1 Tag)
-2.61%
Veränderung (1 Jahr)
-77.76%
Land
CA
Handel BioHarvest Sciences Inc. Common Stock (BHST)
P/S-Verhältnis für BioHarvest Sciences Inc. Common Stock (BHST)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von BioHarvest Sciences Inc. Common Stock beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für BioHarvest Sciences Inc. Common Stock von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
2.88 -
US
- -
CA
- -
CN
- -
US
30.74 -
CN